Docetaxel Plus Cisplatin: In NSCLC

By Toni M. Dando   Karen L. Goa  

American Journal of Cancer, Vol. 2, Iss. 5, 2003-01 ,pp. : 349-356

Adis International

Access to resources Recommend Favorite

Weekly docetaxel and cisplatin plus fluorouracil as a preoperative treatment for gastric cancer patients with synchronous multiple hepatic metastases: a pilot study

By Li Zi-Yu  

Medical Oncology, Vol. 27, Iss. 4, 2010-12 ,pp. : 1314-1318

Humana Press, Inc

Access to resources Recommend Favorite

Docetaxel (taxotere(R)) plus cisplatin: an active and well-tolerated combination in patients with advanced non-small cell lung cancer

By Le Chevalier T.   Monnier A.   Douillard J.Y.   Ruffie P.   Sun X.S.   Belli L.   Ibrahim N.   Bougon N.   Berille J.  

European Journal of Cancer, Vol. 34, Iss. 13, 1998-12 ,pp. : 2032-2036

Elsevier

Access to resources Recommend Favorite

Experience with combination of docetaxel, cisplatin plus 5-fluorouracil chemotherapy, and intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma

By Du Chengrun  

International Journal of Clinical Oncology, Vol. 18, Iss. 3, 2013-06 ,pp. : 464-471

Springer Publishing Company

Access to resources Recommend Favorite

Doublet regimen of cisplatin plus docetaxel for second-line chemotherapy after prior therapy with cisplatin plus irinotecan for non-small cell lung cancer: a phase II study

By Seto Takashi   Takezako Yoriko   Nakamura Hiroko   Takeda Kayo   Inoue Fumiko   Semba Hiroshi   Eguchi Kenji  

International Journal of Clinical Oncology, Vol. 9, Iss. 5, 2004-10 ,pp. : 378-382

Springer Publishing Company

Access to resources Recommend Favorite